OrbusNeich to build largest R&D and production base in Hangzhou, China

OrbusNeich Medical (06929.HK) announced that its wholly-owned subsidiary, OrbusNeich Medical (Zhejiang) Co., Ltd., signed an agreement with Hangzhou Fuchunwan New City Management Committee to invest in a vascular interventional medical device R&D and production base. The project has a fixed asset investment of approximately RMB 300 million, with an annual production capacity of about 2.4 million units after completion.

“集团自去年12月于港交所挂牌上巿以来，一直致力实践企业发展策略，而产能扩充计划是当中重要一环。”zhitongcaijing.com

• 3 sources
• zhitongcaijing.com业聚医疗(06929)拟落户杭州富春湾新城兴建集团最大研发生产设施Mar 28, 2023
• beta.zhitongcaijing.com业聚医疗(06929)拟落户杭州富春湾新城兴建集团最大研发生产设施Mar 28, 2023
• orbusneich.comOrbusNeich Plans to Set up Its Largest R&D and Production Base in Fuchun Bay New Town, Hangzhou, the PRC - OrbusNeichColin ChenMar 28, 2023

Summarized from public sources; check the original articles before acting on it.